<SEC-DOCUMENT>0001193125-23-201740-index.html : 20230802 <SEC-HEADER>0001193125-23-201740.hdr.sgml : 20230802 <ACCEPTANCE-DATETIME>20230802161934 ACCESSION NUMBER: 0001193125-23-201740 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20230802 DATE AS OF CHANGE: 20230802 EFFECTIVENESS DATE: 20230802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-273608 FILM NUMBER: 231135931 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>d515034ds8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: d515034ds8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d515034dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d515034dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>d515034dex232.htm <DESCRIPTION>EX-23.2 <TEXT> Document 3 - file: d515034dex232.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>d515034dexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: d515034dexfilingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g515034g0802102602920.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g515034g0802102602920.jpg
</DOCUMENT> </SEC-DOCUMENT>